Jiwei Nie | Emerging Areas in Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Jiwei Nie | Emerging Areas in Neuroscience | Best Researcher Award

Dr. Jiwei Nie, Haier Group, China.

Jiwei Nie is an accomplished Chinese researcher specializing in Artificial Intelligence-based Pattern Recognition and Intelligent Detection, with a strong focus on AI large models. His academic journey began with a Bachelor’s in Mechanical Design and Automation and evolved into a deeply integrated path through a Master’s and Ph.D. in Control Science and Engineering at Northeastern University. Throughout his doctoral research, he has made notable contributions to the field of Visual Place Recognition (VPR) for autonomous systems, publishing in prestigious journals such as IEEE Transactions on Intelligent Transportation Systems and IEEE Robotics and Automation Letters. Jiwei’s innovations—especially in lightweight, training-free image descriptors and adaptive texture fusion—have positioned him at the forefront of applied AI in robotics and automation. He has also presented at major international conferences and holds multiple patents.

Profile

Google Scholar

🎓 Early Academic Pursuits

 Jiwei Nie displayed a deep interest in engineering and innovation from an early age. His academic journey began at Hebei University of Science and Technology, where he pursued a Bachelor’s degree in Mechanical Design, Manufacturing, and Automation. His strong academic performance earned him first-class honors, and he graduated in July 2018. Motivated to delve deeper into the fusion of machinery and intelligence, he advanced to Northeastern University, completing his Master’s degree in Mechanical and Electronic Engineering by July 2020. Driven by a vision to integrate control systems with intelligent technologies, he enrolled in a PhD program in Control Science and Engineering under a prestigious Integrated Master-PhD track, further solidifying his expertise in the intelligent automation domain.

💼 Professional Endeavors

Jiwei’s professional development has been tightly interwoven with his academic path, where he has continuously applied theoretical insights to practical problems in Artificial Intelligence and Control Systems. As a member of the Communist Party of China, he approaches his work with a strong sense of discipline and public responsibility. His fluency in English, proven by his CET-6 certification, has enabled him to actively contribute to the global research community, engaging in international collaborations and conferences. Alongside his research, Jiwei has contributed to academic circles through mentorship roles and cross-institutional projects, making a significant impact both inside and outside his university.

🤖 Contributions and Research Focus

Jiwei Nie’s research is at the forefront of Artificial Intelligence-based Pattern Recognition and Intelligent Detection, with a special emphasis on AI Large Models. His work focuses on developing lightweight, efficient algorithms for Visual Place Recognition (VPR)—a critical capability for autonomous vehicles and robotic systems. He has pioneered new methods in saliency encoding, feature mixing, and texture fusion, leading to more robust and adaptive AI systems. Through these contributions, he has addressed real-world challenges in long-term navigation and intelligent perception, pushing the boundaries of control science and machine intelligence.

🏆 Accolades and Recognition

During his PhD, Jiwei published multiple high-impact articles in leading SCI-indexed journals. His paper in the IEEE Transactions on Intelligent Transportation Systems, titled “A Training-Free, Lightweight Global Image Descriptor for Long-Term Visual Place Recognition Toward Autonomous Vehicles”, has been particularly well-received and is ranked in Q1. Additional works in IEEE Robotics and Automation Letters have been ranked in Q2, highlighting his innovations such as MixVPR++ and Efficient Saliency Encoding. Furthermore, Jiwei’s presence has been notable at world-class conferences like ICPR, ICRA, and IROS, where he presented his work to a global audience of peers and experts. He also holds several patents, including an invention patent, and continues to submit further manuscripts to top-tier venues.

🌍 Impact and Influence

Jiwei’s research has had a significant influence on the future of intelligent transportation and autonomous systems. His development of training-free VPR models has contributed to making autonomous navigation more scalable and cost-effective, especially in dynamic environments where traditional AI systems fail. His proposed methods are not only academically rigorous but are also computationally efficient, paving the way for real-world deployment. Through his innovation and academic collaborations, he has helped bridge the gap between theoretical AI models and practical engineering applications, which is vital for industries moving toward Industry 4.0 and smart mobility solutions.

🧠 Legacy and Future Contributions

Looking ahead, Jiwei Nie aspires to deepen his research in generalized large AI models, expanding the scalability and generalization abilities of pattern recognition systems across domains beyond transportation—such as smart surveillance, industrial robotics, and medical imaging. His planned future publications and continued patent filings reflect a strong ambition to lead the next generation of intelligent systems research. Jiwei is committed to fostering innovation that aligns with both academic excellence and societal needs, aiming to establish himself as a pioneering researcher and mentor in the evolving field of intelligent detection and AI integration.

🔬 Vision in AI and Control Engineering

Jiwei Nie stands as a rising expert in the convergence of Artificial Intelligence, Control Science, and Robotic Vision, a field essential for the future of smart systems and automation. His deep technical knowledge, coupled with a strategic vision, positions him to contribute not only as a researcher but also as a thought leader in AI-driven engineering. With a career rooted in innovation and societal benefit, his trajectory points toward a legacy of breakthroughs that will influence smart cities, autonomous systems, and global AI research landscapes for years to come.

Publication

  • Title: A survey of extrinsic parameters calibration techniques for autonomous devices
    Authors: J Nie, F Pan, D Xue, L Luo
    Year: 2021

 

  • Title: A training-free, lightweight global image descriptor for long-term visual place recognition toward autonomous vehicles
    Authors: J Nie, JM Feng, D Xue, F Pan, W Liu, J Hu, S Cheng
    Year: 2023

 

  • Title: Forest: A lightweight semantic image descriptor for robust visual place recognition
    Authors: P Hou, J Chen, J Nie, Y Liu, J Zhao
    Year: 2022

 

  • Title: A novel image descriptor with aggregated semantic skeleton representation for long-term visual place recognition
    Authors: J Nie, JM Feng, D Xue, F Pan, W Liu, J Hu, S Cheng
    Year: 2022

 

  • Title: Efficient saliency encoding for visual place recognition: Introducing the lightweight pooling-centric saliency-aware VPR method
    Authors: J Nie, D Xue, F Pan, Z Ning, W Liu, J Hu, S Cheng
    Year: 2024

 

  • Title: 3D semantic scene completion and occupancy prediction for autonomous driving: A survey
    Authors: G Xu, W Liu, Z Ning, Q Zhao, S Cheng, J Nie
    Year: 2023

 

  • Title: A Novel Image Descriptor with Aggregated Semantic Skeleton Representation for Long-term Visual Place Recognition
    Authors: N Jiwei, F Joe-Mei, X Dingyu, P Feng, L Wei, H Jun, C Shuai
    Year: 2022

 

  • Title: Optic Disc and Fovea Localization based on Anatomical Constraints and Heatmaps Regression
    Authors: L Luo, F Pan, D Xue, X Feng, J Nie
    Year: 2021

 

  • Title: A Novel Fractional-Order Discrete Grey Model with Initial Condition Optimization and Its Application
    Authors: Y Liu, F Pan, D Xue, J Nie
    Year: 2021

 

  • Title: EPSA-VPR: A lightweight visual place recognition method with an Efficient Patch Saliency-weighted Aggregator
    Authors: J Nie, Q Zhào, D Xue, F Pan, W Liu
    Year: 2025

 

🔚 Conclusion

With a solid foundation in engineering and control systems and an innovative mindset in artificial intelligence, Jiwei Nie is poised to become a key figure in the evolution of intelligent automation technologies. His work contributes not only to academic theory but also to practical applications that influence the development of autonomous vehicles, intelligent detection systems, and large AI model architectures. As he approaches the completion of his Ph.D. in early 2025, Jiwei is expected to continue pushing technological boundaries, inspiring future advancements in AI research and real-world intelligent systems deployment.

Chen Shoubin | Behavioral Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Chen Shoubin | Behavioral Neuroscience | Best Researcher Award

Dr. Chen Shoubin, Shenzhen University,  China.

Dr. Shoubin Chen is a forward-thinking Research Fellow at the Guangdong Laboratory of Artificial Intelligence and Digital Economy (Shenzhen), affiliated with Shenzhen University. With a Ph.D. in Photogrammetry and Remote Sensing, his career has been rooted in the intersection of spatial intelligence, robotics, and AI. From leading national research projects to publishing in reputable journals and securing multiple invention patents, Dr. Chen has made substantial contributions to the field of embodied intelligent robotics. His research emphasizes multi-sensor fusion and autonomous mapping, aiming to give machines human-like spatial perception and decision-making capabilities.

Profile

Google Scholar

 

📚 Early Academic Pursuits

Shoubin Chen’s academic journey began with a strong foundation in geospatial sciences, culminating in a Ph.D. in Photogrammetry and Remote Sensing in 2020. This prestigious degree was awarded through a rigorous joint training program between Wuhan University and the Finnish Geospatial Research Institute. During his doctoral studies, he developed a deep interest in integrating advanced spatial data techniques with artificial intelligence, laying the groundwork for his future research endeavors. His early academic phase was marked by a commitment to cross-border scientific collaboration and multidisciplinary exploration, which has since defined his research approach.

🧑‍💻 Professional Endeavors

Currently serving as a Research Fellow and graduate supervisor at the Guangdong Laboratory of Artificial Intelligence and Digital Economy (Shenzhen) and Shenzhen University, Dr. Chen plays a pivotal role in advancing embodied intelligence within the Spatial Intelligence Team. His responsibilities include mentoring postgraduate students, overseeing cutting-edge research, and steering major national and provincial scientific projects. He has contributed to several national-level initiatives, including two National Natural Science Foundation of China grants, support from the China Postdoctoral Science Foundation, and sub-projects under the National Key Research and Development Program. These experiences have sharpened his expertise in high-precision robotic mapping and autonomous navigation.

🤖 Contributions and Research Focus

Dr. Chen’s primary research focus lies in embodied intelligent robotics, with an emphasis on multi-sensor fusion, robotic perception, and spatial mapping technologies. He is recognized for integrating data from various sensing modalities to improve the autonomy and spatial awareness of robotic systems. His innovations aim to empower robots with human-like spatial understanding, allowing them to operate reliably in complex environments. This research direction is crucial for applications ranging from autonomous vehicles to intelligent service robots, contributing significantly to the frontier of AI-driven robotics.

🏅 Accolades and Recognition

Throughout his academic and professional career, Shoubin Chen has garnered considerable recognition for his scientific excellence. He has published nearly ten high-quality papers as either the first or corresponding author in SCI Q2 journals and CCF B-tier or higher conferences and journals. Moreover, he has applied for over ten invention patents, underscoring his commitment to both theoretical advancement and practical application. His reputation in the academic community is further highlighted by his service as a peer reviewer for prestigious platforms such as the IEEE Internet of Things Journal, Remote Sensing of Environment, IEEE Transactions on Intelligent Vehicles, and ICRA, one of the top robotics conferences globally.

🌐 Impact and Influence

Dr. Chen’s work has had a profound impact on the fields of AI, robotics, and spatial computing. His multi-disciplinary approach has influenced how robots understand and interact with their environments, offering transformative possibilities in smart cities, autonomous transport, and digital mapping. By fusing photogrammetry with robotics and AI, he has contributed to a new paradigm in spatial intelligence that bridges digital perception and physical action. His projects have not only generated academic outputs but have also driven technological innovations with potential for real-world deployment.

🌱 Legacy and Future Contributions

As a mentor, innovator, and research leader, Shoubin Chen continues to inspire the next generation of scientists and engineers in AI and robotics. His forward-looking vision involves deepening the integration of embodied intelligence with environmental understanding, enabling machines to collaborate more intuitively with humans. He is poised to expand his research to include human-robot interaction, sustainable urban intelligence, and smart sensing systems. With a growing portfolio of publications, patents, and mentorship experiences, his contributions are set to leave a lasting legacy in the development of intelligent systems that seamlessly bridge perception and action.

🔬 Vision in Artificial Intelligence and Robotics

Guided by a vision that combines spatial science with artificial cognition, Dr. Chen’s work embodies the future of AI-powered robotics. His pursuit of intelligent, context-aware robotic systems aligns with global goals in automation, smart infrastructure, and digital economy. As AI becomes increasingly pervasive in everyday life, his contributions are steering the technology toward safer, more efficient, and more interactive systems. Through continuous innovation and collaboration, he remains at the forefront of a transformative research frontier that blends engineering precision with visionary thinking.

Publication

  • Title: Exploring embodied multimodal large models: Development, datasets, and future directions
    Authors: S Chen, Z Wu, K Zhang, C Li, B Zhang, F Ma, FR Yu, Q Li
    Year: 2025

 

  • Title: Distributed Robust Communication-Efficient Multi-Robot SLAM Combining Real-Time Intersection and Historical Loop Constraints
    Authors: B Zhang, Z Xiong, J Qiu, S Chen, Y Hu, S Chen
    Year: 2025

 

  • Title: TextGeo-SLAM: A LiDAR SLAM With Text Semantics and Geometric Constraints-Based Loop Closure
    Authors: S Chen, C Li, Q Jiang, X Zhuang, B Zhang, B Zhou, Q Li
    Year: 2024

 

  • Title: ASL-SLAM: A LiDAR SLAM with activity semantics-based loop closure
    Authors: B Zhou, C Li, S Chen, D Xie, M Yu, Q Li
    Year: 2023

 

  • Title: Comparative analysis of SLAM algorithms for mechanical LiDAR and solid-state LiDAR
    Authors: B Zhou, D Xie, S Chen, H Mo, C Li, Q Li
    Year: 2023

 

  • Title: Research on SLAM based on LiDAR/visual fusion (LV-SLAM)
    Authors: C Shoubin
    Year: 2023

 

  • Title: Cooperative smartphone GNSS/PDR for pedestrian navigation
    Authors: C Jiang, Y Chen, C Chen, S Chen, Q Meng, Y Bo, J Hyyppa
    Year: 2022

 

  • Title: Indoor Attitude Estimation Using Equipped Gyroscopes and Depth Sensors
    Authors: Q Shi, Z Song, Z Xiao, S Chen, F Wang
    Year: 2022

 

  • Title: LI-SLAM: Fusing LiDAR and Infrared Camera for Simultaneous Localization and Mapping
    Authors: B Zhou, D Xie, S Chen, C Li, H Mo
    Year: 2022

 

  • Title: NDT-LOAM: A real-time LiDAR odometry and mapping with weighted NDT and LFA
    Authors: S Chen, H Ma, C Jiang, B Zhou, W Xue, Z Xiao, Q Li
    Year: 2021

 

✅ Conclusion

In conclusion, Dr. Shoubin Chen exhibits all the core qualities of a Best Researcher Award recipient: deep scientific insight, proven research leadership, strong publication and patent output, and a visionary approach to solving real-world problems through AI and robotics. While there are opportunities to grow his international footprint, his current accomplishments already place him among the leading young researchers in his field. Based on the evidence of impact, innovation, and research excellence, he is highly suitable for the Best Researcher Award.

Atena Shojaie | Behavioral Neuroscience | Best Researcher Award

Published on by Neuroscientists

Ms. Atena Shojaie | Behavioral Neuroscience | Best Researcher Award

Ms. Atena Shojaie, Kerman university of medical sciences, Iran.

Atena Shojaie is a dedicated medical-surgical nursing professional with a Master’s degree from Kerman University of Medical Sciences. Her early academic journey was marked by a passion for integrating clinical care with research, particularly in neurology and rehabilitation. Over three years of working in critical care settings, including Neurology and ICU wards, she honed her clinical expertise while also serving as a valued clinical instructor. Her research focus on guided imagery as a therapeutic intervention for multiple sclerosis and MRI-induced anxiety has led to innovative practices currently in use at major hospitals. Atena’s academic contributions are beginning to gain recognition through citations and clinical adoption of her methods.

Profile

Google Scholar

 

🎓 Early Academic Pursuits

Atena Shojaie began her journey in the field of healthcare with a strong academic foundation, earning a bachelor’s degree in nursing followed by a Master of Science in Medical-Surgical Nursing from Kerman University of Medical Sciences. Her early academic interests revolved around holistic patient care and neuro-rehabilitation, which laid the groundwork for her later clinical and research endeavors. During her postgraduate studies, she demonstrated a deep commitment to understanding patient needs—especially those facing neurological challenges—while also refining her clinical skills in hospital environments.

🏥 Professional Endeavors

In the span of just three years, Atena accumulated extensive experience working in several critical hospital wards, including Neurology, Neurosurgery, and the Intensive Care Unit (ICU). Her hands-on experience with acute and chronic conditions shaped her clinical intuition and enhanced her ability to manage complex patient cases. Parallel to her clinical work, she embraced the role of a clinical instructor, mentoring nursing and emergency medical students with a balance of academic rigor and compassionate teaching. This dual role of caregiver and educator reflects her deep-seated dedication to both practice and pedagogy.

🔬 Contributions and Research Focus

Atena’s research primarily centers on the intersection of psychological interventions and physical rehabilitation, with a particular emphasis on multiple sclerosis (MS). Her master’s thesis, “The Effectiveness of Guided Imagery on Walking and Balance Dysfunction in Patients With Multiple Sclerosis,” stands as a cornerstone of her academic work. The project demonstrated measurable improvements in gait and balance among MS patients and has since influenced ongoing clinical practices. Additionally, she completed a significant study on the “Anxiety of Patients Undergoing Magnetic Resonance Imaging (MRI),” showing how guided imagery can alleviate pre-procedure stress—further reflecting her commitment to patient-centered innovations.

🧠 Innovations in Mental Imagery

Atena Shojaie has been instrumental in translating academic research into practical tools for patient care. One of her notable innovations includes the creation of a guided imagery audio file, which is now regularly used in two major healthcare centers—Bahonar Hospital’s MRI department and Shafa Hospital’s MS Clinic. This therapeutic tool has not only improved the mental well-being of patients but also contributed to smoother clinical workflows, particularly in high-anxiety environments like radiology units.

📈 Impact and Influence

Although still early in her research career, Atena’s work has begun to gain scholarly recognition. With a citation index that includes three citations and an h-index of 1, her research is already laying the foundation for future studies in neuro-nursing and psychological rehabilitation. Her work continues to resonate with clinical teams and academics alike, especially those focused on non-pharmacological interventions for neurological conditions.

🏅 Accolades and Recognition

Atena’s clinical and research activities have earned her respect among her peers and mentors at Kerman University of Medical Sciences. While formal awards may still be on the horizon, her true recognition lies in the adoption of her guided imagery methods by major hospitals—an endorsement of both her scientific rigor and clinical insight. Her role as a trusted clinical instructor further affirms her reputation as a knowledgeable and compassionate professional.

🌟 Legacy and Future Contributions

With a solid foundation in research and hands-on care, Atena Shojaie is poised to make enduring contributions to the field of neuro-rehabilitative nursing. Her vision includes expanding the use of therapeutic mental imagery in broader hospital settings and conducting multi-center studies to further validate its effectiveness. As she continues her academic and clinical journey, her legacy will likely be defined by a thoughtful fusion of science, compassion, and innovation—paving the way for future advancements in holistic patient care.

Publication

 

  • Anxiety of Patients Undergoing Magnetic Resonance Imaging (MRI): The Effectiveness of Guided Mental Imagery
    Authors: A. Shojaie, H. Amiri, T. Dehesh, B. Bagherian
    Year: 2024

 

  • The Effectiveness of Guided Imagery on Walking and Balance Dysfunction in Patients With Multiple Sclerosis: A Randomized Controlled Trial
    Authors: B.B. Atena Shojaie, Hoda Kamali, Monir Sadat Nematollahi, Zahra Imani Goghary
    Year: 2025

 

✅ Conclusion

Atena Shojaie exemplifies the new generation of nurse-researchers who bridge the gap between evidence-based practice and compassionate patient care. Her work in guided mental imagery not only addresses physical dysfunction but also supports patients’ emotional and psychological needs. As she continues to expand her research and clinical impact, Atena is well-positioned to influence future standards in neuro-nursing and non-pharmacological therapy. Her legacy will likely be defined by innovation, empathy, and a relentless pursuit of better outcomes for patients with neurological conditions.

Hao Lai | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Hao Lai | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Hao Lai, Zhongshan Hospital, Fudan University, China.

Dr. Hao Lai is a distinguished cardiovascular surgeon and researcher, currently serving as Chief Physician at Zhongshan Hospital, Fudan University. With over 20 years of clinical expertise, he specializes in aortic and cardiovascular surgery. His academic achievements include a Ph.D. in Surgery from Fudan University and significant contributions to the study of epigenetic mechanisms in thoracic aortic dissection. As a principal investigator of nationally funded projects and co-author of influential publications, Dr. Lai combines scientific rigor with clinical innovation. He has also played a key role in medical education and device development through industry collaboration.

Profile

Scopus

 

🎓 Early Academic Pursuits

Dr. Hao Lai began his academic journey with a strong foundation in medical sciences, culminating in a Ph.D. in Surgery from the prestigious Fudan University. His early academic pursuits were marked by a deep interest in cardiovascular physiology and surgical intervention, which later matured into a specialized focus on aortic diseases. His time as a doctoral candidate not only equipped him with rigorous scientific training but also ignited his lifelong commitment to solving complex clinical problems through research.

🏥 Professional Endeavors

Currently serving as Chief Physician at Zhongshan Hospital, Fudan University, Dr. Hao Lai has accumulated over two decades of extensive clinical experience in cardiovascular and aortic surgery. His professional trajectory reflects a seamless integration of surgical excellence with academic leadership. At Zhongshan Hospital, a leading institution in China, he has spearheaded several clinical programs aimed at enhancing patient outcomes in cases of thoracic aortic dissection and other high-risk cardiovascular conditions.

🔬 Contributions and Research Focus

Dr. Lai’s research centers around the epigenetic mechanisms underlying thoracic aortic dissection, with a particular focus on histone modification and DNA methylation. He is the Principal Investigator of a major research project funded by the National Natural Science Foundation of China, which explores the role of H3K36me3 histone modification and DNMT3B-mediated gene body methylation in the pathogenesis of aortic dissection. His scientific efforts bridge molecular pathology with clinical implications, offering new perspectives on the diagnosis and treatment of life-threatening vascular disorders.

🏆 Accolades and Recognition

A respected voice in cardiovascular medicine, Dr. Hao Lai has co-authored numerous influential articles in high-impact journals such as Cardiovascular Research and Advanced Science. His h-index of 18, as listed on Scopus, reflects his consistent scholarly output and the wide academic acknowledgment of his work. In addition, his authorship of the textbook Practical Surgery (3rd Edition), published by People’s Medical Publishing House, stands as a testament to his educational contributions to the next generation of Chinese surgeons.

🧪 Impact and Innovation

Dr. Lai’s research has made a tangible impact on the understanding and treatment of aortic diseases. His investigation into the epigenetic regulation of vascular pathology has opened new avenues for targeted therapies. Moreover, his collaboration with MicroPort Endovascular MedTech demonstrates his commitment to translating research findings into real-world applications, particularly in the development and refinement of endovascular surgical devices.

🌍 Influence and Collaboration

Beyond his direct research and surgical contributions, Dr. Lai’s influence extends into collaborative domains, both nationally and internationally. His leadership in high-level research grants, clinical trials, and industrial partnerships positions him as a central figure in the evolving landscape of cardiovascular surgery. His collaborative spirit fosters innovation and promotes cross-disciplinary dialogue, essential in today’s complex medical research environment.

🔮 Legacy and Future Contributions

As Dr. Hao Lai continues his distinguished career, his legacy is being shaped not only by his surgical accomplishments but also by his contributions to medical science. His ongoing projects are likely to further clarify the molecular landscape of aortic diseases and inspire new therapeutic strategies. Looking ahead, Dr. Lai is poised to remain at the forefront of cardiovascular innovation, committed to improving patient care through a synthesis of research, education, and clinical practice.

Publication

 

Title: Prevalence and predictors of left atrial thrombus in patients with rheumatic atrial fibrillation undergoing cardiac surgery: a cross-sectional study
Authors: J. Cui, Y. Zhang, Y. Wang, Q. Ji, C. Wang
Year: 2025


Title: A novel open-vascular single-branched stent graft in total arch repair of type A aortic dissection one-year results of a prospective multicenter randomized controlled study
Authors: J. Gu, W. Zhang, L. Kang, H. Lai, C. Wang
Year: 2025


Title: Fibroblast Activation Protein Acts as a Biomarker for Monitoring ECM Remodeling During Aortic Aneurysm via 68Ga-FAPI-04 PET Imaging
Authors: C. Hu, H. Tan, Y. Zhang, X. Chen, L. Wang
Year: 2025


Title: Mitochondrial NAD+ deficiency in vascular smooth muscle impairs collagen III turnover to trigger thoracic and abdominal aortic aneurysm
Authors: J. Zhang, Y. Tang, S. Zhang, K. Zhu, W. Zhang
Year: 2025


Title: Correcting mitochondrial loss mitigates NOTCH1-related aortopathy in mice
Authors: Y. Tang, J. Zhang, Y. Fang, Y. Xu, W. Zhang
Year: 2025


Title: Exploration of 68Ga-FAPI-04 PET/MR in Chronic Type B Aortic Dissection
Authors: C. Hu, Y. Zhang, S. Qiu, H. Shi, L. Wang
Year: 2025


Title: Effects of postoperative glucocorticoids on mitigation of organ dysfunction in patients with type A aortic dissection: A randomized controlled trial
Authors: M. Luo, J. Luo, X. Xu, G. Tu, Z. Luo
Year: 2024


Title: Therapeutic results of three-dimensional aortic valve anatomic repair for regurgitant bicuspid aortic valve
Authors: J. Li, C. Wang, Z. Zuo, W. Ding, T. Hong
Year: 2024


Title: 68Ga-FAPI-04 Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Ascending Aortic Aneurysm
Authors: C. Hu, H. Tan, Y. Zhang, H. Lai, L. Wang
Year: 2024


Title: Sex-based outcomes after thoracic endovascular aortic repair: A systematic review and meta-analysis
Authors: Y. Zhang, Y. Zhang, Y. Wang, L. Wang, Q. Ji
Year: 2025

✅ Conclusion

Dr. Hao Lai’s career represents a powerful blend of surgical precision, scientific insight, and academic leadership. His work has advanced the understanding of aortic diseases at the molecular level while improving surgical outcomes for patients. As he continues to mentor, innovate, and lead research at the intersection of epigenetics and cardiovascular pathology, Dr. Lai’s contributions are set to leave a lasting legacy in both clinical practice and medical science.

 

 

Lijuan Song | Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Lijuan Song | Cellular Neuroscience | Best Researcher Award

Prof. Lijuan Song,  Shanxi University of Chinese Medicine, China.

Throughout my career, I have passionately committed myself to integrating traditional Chinese medicine and Western medicine to advance the prevention and treatment of brain diseases, particularly ischemic cerebrovascular diseases and neurodegenerative disorders. By leading 14 national and provincial-level research projects, publishing over 130 academic papers, and contributing significantly to educational reform, I have built a strong foundation of scientific innovation and clinical excellence. With achievements recognized both nationally and internationally, and a consistent focus on combining research, teaching, and clinical work, I have significantly impacted the fields of neuroprotection and integrative medicine.

Profile

Scopus

 

🎓 Early Academic Pursuits

From the outset of my academic journey, I committed myself to the profound study of both traditional Chinese medicine and Western medicine, aspiring to bridge these two disciplines for the betterment of brain disease treatment. I pursued a rigorous path of education and research, laying a strong foundation that later allowed me to integrate diverse medical perspectives. Early in my career, I developed a particular interest in ischemic cerebrovascular diseases and neurodegenerative conditions, setting the stage for my lifelong mission to innovate in these critical areas.

🩺 Professional Endeavors

My professional career has been a dynamic blend of teaching, clinical practice, and scientific research, with a special focus on the prevention and treatment of brain diseases. I have successfully presided over 14 prestigious national and provincial-level projects, including those funded by the National Natural Science Foundation of China and the China Postdoctoral Science Foundation. Through my work, I have consistently emphasized the value of integrating traditional Chinese medicine with modern Western practices, ensuring that my clinical and research contributions are both culturally rooted and globally relevant.

🔬 Contributions and Research Focus

Throughout my research journey, I have concentrated on ischemic cerebrovascular diseases and neurodegenerative diseases, pioneering integrated approaches for their prevention and treatment. I have published 133 scientific papers, including 45 in SCI-indexed journals, with nearly 700 citations and an H-index of 15. One of my papers published in Neural Regeneration Research (NRR) has been recognized in the ESI highest citation list, achieving an impressive 97 citations. Beyond scientific research, I have also contributed significantly to educational innovation, authoring educational reform articles in the China Journal of Traditional Chinese Medicine and editing influential academic books.

🏆 Accolades and Recognition

My dedication to scientific advancement and education has earned me multiple prestigious honors. As the first author, I received the First Prize of the Academic Achievement Award from the China Association for the Promotion of Traditional Chinese Medicine Research. I have secured three authorized patents and two software copyrights, further showcasing my commitment to innovation. Additionally, my work has been featured through oral presentations at internationally renowned academic forums such as the Autoimmunity Congress and the World Stroke Congress, and recognized by respected platforms like Logic Neuroscience and Neuroweekly.

🌍 Impact and Influence

My influence extends beyond academia into public science education and medical philosophy dialogues. I have been repeatedly invited to deliver popular science talks and academic lectures at events like the Medical Philosophy Expert Meeting Room. My presentation at the 2022 International Neural Regeneration Summit Forum earned the Most Popular Award, affirming my ability to translate complex research into impactful and accessible knowledge for diverse audiences.

📚 Legacy in Education and Publishing

In addition to research and clinical achievements, I have made significant contributions to academic publishing and educational reform. My independently authored book, Progress in Integrated Traditional Chinese and Western Medicine Prevention and Treatment of Ischemic Cerebrovascular Disease, was published by People’s Health Publishing House. I have served as the first editor-in-chief for three important books, including Exploration of Teaching Models in Higher Education Pharmaceutical Education, which was honored by its selection into the “Library of Young Scholars in Universities,” marking a lasting contribution to the future of pharmaceutical education.

🚀 Future Contributions and Aspirations

Looking ahead, I aspire to further deepen the integration of traditional Chinese and Western medicine, particularly in brain disease prevention and therapy. I am committed to leading new research directions, fostering international collaborations, and nurturing a new generation of scholars who value the richness of cross-cultural medical practices. My future endeavors will continue to reflect a relentless pursuit of scientific excellence, compassionate clinical practice, and transformative education for the global health community.

Publication

  • Title: Effect of tetramethylpyrazine on neuroinflammation after cerebral ischemia and hypoxia based on mannose-binding lectin
    Authors: Y. Duan, Yanzhe; J. Hua, Jianlin; Y. Yan, Yuqing; L. Song, Lijuan
    Year: 2025

 

  • Title: Polysaccharides from Ganoderma lucidum attenuate cognitive impairment in 5xFAD mice by inhibiting oxidative stress and modulating mitochondrial dynamics via the Nrf2/antioxidative axis activation
    Authors: J. Yu, Jiezhong; C. Ma, Cungen
    Year: 2025

 

  • Title: Hydroxysafflower yellow A alleviates the inflammatory response in astrocytes following cerebral ischemia by inhibiting the LCN2/STAT3 feedback loop
    Authors: L. Song, Lijuan; Y. Wu, Yige; L. Yin, Lijun; B. Xiao, Baoguo; C. Ma, Cungen
    Year: 2025

 

  • Title: Mechanism of senegenin in improving lipopolysacchride-induced inflammatory response of BV2 microglial cell
    Authors: B. Mu, Bingtao; M. Guo, Minfang; J. Yu, Jingwen; J. Yu, Jiezhong; L. Song, Lijuan
    Year: 2025

 

  • Title: Effectiveness and Safety of Blending Traditional Chinese Medicine With Western Medicine for Enhanced Secondary Stroke Prevention: A Meta-analysis of RCTs
    Authors: C. Wen, Chunli; L. Song, Lijuan; C. Ma, Cungen; F. Hu, Fengyun; L. Zhu, Linggqun
    Year: 2025

 

 

🎯 Conclusion

Driven by a deep belief in the power of integration between ancient wisdom and modern science, I have continuously sought to pioneer new frontiers in brain disease treatment. My work has not only advanced research but also nurtured future generations through educational contributions and public science communication. Moving forward, I remain committed to expanding the reach and depth of integrated medicine, aiming to create a lasting legacy of innovation, healing, and academic excellence for global healthcare advancement.

CARMINA MONTOLIU | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. CARMINA MONTOLIU | Clinical Neuroscience | Best Researcher Award

Prof. Dr.  CARMINA MONTOLIU, UNIVERSIDAD DE VALENCIA/INCLIVA,  Spain.

Carmina Montoliu Felix, a Valencia-born scientist and educator, is a distinguished Catedrática de Universidad at the Universidad de Valencia, specializing in Cellular Biology and Pathology. With a strong foundation in biomedical sciences and a dual role in both academia and clinical research through INCLIVA, she has become a key figure in translational medicine in Spain. Her work focuses on uncovering cellular mechanisms of disease, supported by national recognition such as her Group A classification by ISCIII. With extensive contributions indexed on platforms like ORCID and Scopus, she has gained international visibility and continues to influence the fields of pathology and biomedicine.

Profile

Orcid

 

🎓 Early Academic Pursuits

Carmina Montoliu Felix was born in Valencia, where she also pursued her academic career rooted in the life sciences. Her early interest in biology and medical sciences led her through a rigorous academic pathway that would eventually shape her into a leading figure in cellular pathology. With a profound dedication to understanding human disease at the cellular level, she cultivated a strong foundation in biology, which became the cornerstone of her future specialization in Cellular Biology and Pathology. These formative years instilled in her a passion for translational research, which continues to drive her work.

🏛️ Professional Endeavors

Currently serving as a Catedrática de Universidad at the Facultad de Medicina y Odontología of the Universidad de Valencia, Carmina Montoliu Felix holds a prestigious position within the Departamento de Patología, specifically in the Unidad de Biología. She achieved this distinguished academic rank on November 3, 2023, under BOE nº 274, a recognition of her academic excellence and contributions to higher education. Alongside her academic post, she is also an investigadora adscrita at the Fundación INCLIVA, playing a dual role in both teaching and active biomedical research. Her employment reflects the seamless integration between university instruction and clinical research aimed at improving patient outcomes.

🧬 Contributions and Research Focus

Carmina Montoliu Felix has been a pivotal contributor to the field of Cellular Biology, with specific expertise in Pathology (Área 661). Since February 29, 2012, she has been classified as a Group A Researcher within the Instituto de Salud Carlos III (ISCIII) framework. Her research activities are aligned with the Programa de Estabilización de Investigadores and the Sistema Nacional de Salud (I3SNS), focusing on intensifying biomedical research and fostering translational discoveries. Her scientific work is characterized by its interdisciplinary nature and commitment to uncovering the molecular basis of diseases, contributing significantly to both national and international health research landscapes.

🏅 Accolades and Recognition

Dr. Montoliu Felix’s academic excellence has been affirmed through numerous accolades, including the Group A classification by the Comisión Técnica de Evaluación de Recursos Humanos del ISCIII, one of the highest distinctions for biomedical researchers in Spain. Her appointment as a full professor is a testament to her leadership in medical education and scientific research. She is widely recognized among her peers for her scholarly impact, rigor, and commitment to nurturing future scientists and medical professionals.

🌍 Impact and Influence

Her work not only resonates within academic circles but also extends into clinical research through her active role at INCLIVA. By integrating research and practice, Carmina Montoliu Felix exemplifies how scientific inquiry can lead to tangible health benefits. Her influence spans collaborations with national healthcare systems and academic institutions, reinforcing her role as a key figure in the biomedical field. Through platforms such as ORCID and Scopus (ORCID ID: 0000-0002-4740-4788; Scopus ID: 6701923138), her contributions are accessible globally, further amplifying her scientific impact.

🔬 Legacy and Future Contributions

With a career marked by consistent advancement and dedication to discovery, Carmina Montoliu Felix is poised to continue shaping the future of cellular pathology and biomedical research in Spain and beyond. Her dual engagement in academia and clinical research ensures that her legacy will include both scientific breakthroughs and a generation of inspired students and researchers. Looking ahead, she is expected to further expand the integration of molecular biology into clinical diagnostics, ultimately improving patient care through science.

📚 A Life Committed to Science and Society

Beyond her technical expertise and professional roles, Carmina Montoliu Felix embodies the ideals of a scholar deeply committed to the betterment of society through science. Her residence and professional base in Valencia, her continuous academic contributions, and her service within public institutions paint the portrait of a researcher who bridges the lab and the community. Through her enduring efforts, she not only advances knowledge but also enhances the collective understanding of human health and disease.

Publication

  • Title: Valproate Damaging Effect on Erythrocyte Metabolism as a Decisive Factor in the Development of Encephalopathy
    Authors: Lyudmila Tikhonova; Eugene Maevsky; Carmina Montoliu; Elena Kosenko
    Year: 2025

 

  • Title: Ammoniagenic Action of Valproate without Signs of Hepatic Dysfunction in Rats: Possible Causes and Supporting Evidence
    Authors: Gubidat Alilova; Lyudmila Tikhonova; Carmina Montoliu; Elena Kosenko
    Year: 2024

 

  • Title: Automatic Video-Oculography System for Detection of Minimal Hepatic Encephalopathy Using Machine Learning Tools
    Authors: Alberto Calvo Córdoba; Cecilia Elisabet García Cena; Carmina Montoliu
    Year: 2023

 

  • Title: Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients
    Authors: Alessandra Fiorillo; Juan José Gallego Roig; Franc Casanova; Amparo Urios; MP Ballester; Teresa San-Miguel; Javier Megías Vericat; Elena Kosenko; Tosca J; Maria-Pilar Rios et al.
    Year: 2023

 

  • Title: Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver Disease
    Authors: Alessandra Fiorillo; Juan José Gallego Roig; Franc Casanova; Carla Giménez-Garzó; Amparo Urios; MP Ballester; Lucia Durbán; Maria-Pilar Rios; Javier Megías Vericat; Teresa San-Miguel et al.
    Year: 2023

 

  • Title: Erythrocytes Functionality in SARS-CoV-2 Infection: Potential Link with Alzheimer’s Disease
    Authors: Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Carmina Montoliu
    Year: 2023

 

  • Title: Plasma Extracellular Vesicles Play a Role in Immune System Modulation in Minimal Hepatic Encephalopathy
    Authors: Juan José Gallego; Alessandra Fiorillo; Franc Casanova-Ferrer; Amparo Urios; MP Ballester; Lucia Durbán; Javier Megías; Teresa Rubio; Andrea Cabrera-Pastor; Desamparados Escudero-García et al.
    Year: 2022

 

  • Title: Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression
    Authors: Teresa San-Miguel; Javier Megías; Daniel Monleon; Lara Navarro Cerveró; Lisandra Muñoz; Carmina Montoliu; Marina Meri; Pedro Roldán; Miguel Cerdá-Nicolás; Concha López-Ginés
    Year: 2022

 

  • Title: Is NMDA-Receptor-Mediated Oxidative Stress in Mitochondria of Peripheral Tissues the Essential Factor in the Pathogenesis of Hepatic Encephalopathy?
    Authors: Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Carmina Montoliu
    Year: 2022

 

  • Title: A New Score Unveils a High Prevalence of Mild Cognitive Impairment in Patients with Nonalcoholic Fatty Liver Disease
    Authors: Carla Giménez-Garzó; Alessandra Fiorillo; MP Ballester; Juan José Gallego Roig; Franc Casanova-Ferrer; Amparo Urios; Salvador Benlloch; Marti-Aguado D; Teresa San-Miguel; Tosca J et al.
    Year: 2021

 

✅ Conclusion

Carmina Montoliu Felix’s career reflects a rare blend of scientific rigor, academic leadership, and social impact. Her journey from student to full professor showcases her dedication to advancing both knowledge and healthcare. As she continues to lead research at the intersection of cellular biology and clinical application, her legacy will not only be measured in published studies and prestigious titles, but also in the real-world health outcomes and inspired minds her work cultivates. Her future contributions promise to deepen our understanding of disease and strengthen the bridge between science and society.

 

Nai-Bing Gu | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Nai-Bing Gu | Clinical Neuroscience | Best Researcher Award

Dr. Gu Naibing is a distinguished Chief Physician in the Department of Neurology at Xi’an Central Hospital, specializing in neuroimmunology. He has made significant contributions to the understanding of neurological diseases, particularly those related to autoimmune and inflammatory conditions of the nervous system. As a Master’s degree supervisor and an active member of several professional committees, Dr. Gu has established himself as a leader in the fields of neurology and neuroimmunology. His research, clinical expertise, and involvement in medical organizations have earned him recognition and influence in the medical community. His work continues to have a lasting impact on both the treatment of neurological diseases and the education of future healthcare professionals.

Profile

Scopus

 

👨‍⚕️ Early Academic Pursuits

Dr. Gu Naibing embarked on his academic journey with a keen interest in neurology and medicine. After completing his medical degree, he pursued further studies in the specialized field of neurology, which led to the completion of his Master’s degree. Throughout his academic tenure, Dr. Gu consistently demonstrated a strong dedication to advancing his understanding of complex neurological conditions. His early academic endeavors set the foundation for a career focused on improving patient outcomes and advancing scientific knowledge in neuroimmunology.

💼 Professional Endeavors

Dr. Gu Naibing has established himself as a prominent figure in the field of neurology. As a Chief Physician in the Department of Neurology at Xi’an Central Hospital, he plays a vital role in diagnosing and treating a wide range of neurological disorders. Additionally, he serves as a Master’s degree supervisor, contributing to the training and development of the next generation of medical professionals. His professional network includes multiple roles in prestigious committees, such as the Neuroimmunology Professional Committee of the Shaanxi Provincial International Medical Exchange Promotion Association and the Neurology Branch of the Xi’an Medical Association.

🔬 Contributions and Research Focus

Dr. Gu’s research primarily focuses on neuroimmunology, the intersection of the immune system and neurological diseases. His work has advanced understanding in this field, particularly with regard to the mechanisms underlying autoimmune disorders affecting the nervous system. By contributing to a deeper understanding of brain diseases, Dr. Gu’s research has had significant implications for the development of more effective treatments for patients suffering from conditions such as multiple sclerosis, encephalitis, and other neuroinflammatory disorders. His focus on integrating immunological and neurological disciplines has been pivotal in pushing the boundaries of clinical research.

🏆 Accolades and Recognition

Throughout his career, Dr. Gu Naibing has earned several accolades and recognition for his outstanding contributions to the medical field. His involvement in various professional committees highlights his leadership and influence in the realm of neurology and neuroimmunology. As a standing committee member of the Neuroimmunology Group and the Neurology Professional Committee of the Shaanxi Health Care Association, Dr. Gu’s expertise and leadership are regularly sought after. His recognition extends beyond clinical practice, as he is frequently invited to contribute to national and international discussions on neurological care and research.

🌍 Impact and Influence

Dr. Gu Naibing’s influence extends beyond his clinical and research activities. Through his active involvement in professional organizations, he has had a profound impact on the development of neurology and neuroimmunology practices in China. His leadership in committees, particularly within the Shaanxi Medical Communication Association, has helped bridge gaps between medical professionals, facilitating the exchange of ideas and research findings. His dedication to fostering collaboration among medical communities has contributed to the enhancement of healthcare practices and the overall improvement of patient care.

🧠 Legacy and Future Contributions

As Dr. Gu Naibing continues his work, his legacy in the fields of neurology and neuroimmunology will undoubtedly inspire future generations of healthcare professionals. His commitment to advancing both clinical and research practices ensures that his contributions will have a lasting impact on the treatment of neurological diseases. Looking ahead, Dr. Gu is poised to continue making significant strides in neuroimmunology, with ongoing research and collaborations aimed at developing new therapeutic approaches. His future contributions promise to further shape the landscape of neurological healthcare, enhancing the lives of patients around the world.

🌟 Final Thoughts

Dr. Gu Naibing’s career has been defined by his passion for neurology, his commitment to advancing research, and his tireless efforts to improve patient outcomes. As a clinician, educator, and researcher, he has earned the respect and admiration of his peers, contributing significantly to the advancement of medical knowledge and patient care. With his continued dedication to the field, Dr. Gu’s legacy is sure to endure, influencing both the scientific community and the generations of healthcare professionals who follow in his footsteps.

Publication

  • Title: Effect of BMSCs overexpressing intelectin-1 on angiogenesis in rats with cerebral infarction
    Authors: B. Zhu, K. Guo, L. Zha, L. Chang, N. Gu
    Year: 2025

 

  • Title: Salivary duct carcinoma presenting with unilateral multiple cranial nerve lesions and concurrent intracranial metastasis: A case report
    Authors: B. Zhu, Q. Zhang, K. Guo, Y. Yang, X. Jia
    Year: 2025

 

Conclusion

Dr. Gu Naibing’s career is a testament to his dedication to advancing the field of neurology and neuroimmunology. His groundbreaking research, leadership in medical committees, and commitment to education have shaped the future of neurological care in China. With his continued focus on improving patient care and expanding scientific knowledge, Dr. Gu is poised to make lasting contributions that will positively impact both the medical field and the lives of countless patients. His legacy will inspire future generations of researchers and clinicians in the realm of neurology.

 

Jun Liu | Neuroimaging | Best Researcher Award

Published on by Neuroscientists

Prof.Dr. Jun Liu | Neuroimaging | Best Researcher Award

Prof. Dr. Jun Liu,  Department of Radiology, Second Xiangya Hospital of Central South University, China.

Professor Jun Liu is a highly accomplished radiologist and academic leader, serving as the Chief Radiologist and Director of the Radiology Department at the Second Xiangya Hospital, Central South University. With a strong foundation in medical sciences and an early passion for radiology, he has emerged as a national figure in neuroimaging and neuroregeneration research. His professional journey is marked by impactful roles in academic mentorship, hospital administration, and national medical organizations. His research excellence is evident through his leadership in multiple prestigious committees and his contributions to scientific review and innovation. Recognized by both government and medical associations, Professor Liu is a decorated figure, celebrated for his medical service during COVID-19 and his scientific leadership in Hunan Province and beyond.

Profile

Orcid 

Scopus

 

Professor Jun Liu is a highly accomplished radiologist and academic leader, serving as the Chief Radiologist and Director of the Radiology Department at the Second Xiangya Hospital, Central South University. With a strong foundation in medical sciences and an early passion for radiology, he has emerged as a national figure in neuroimaging and neuroregeneration research. His professional journey is marked by impactful roles in academic mentorship, hospital administration, and national medical organizations. His research excellence is evident through his leadership in multiple prestigious committees and his contributions to scientific review and innovation. Recognized by both government and medical associations, Professor Liu is a decorated figure, celebrated for his medical service during COVID-19 and his scientific leadership in Hunan Province and beyond.

Profile

Orcid
Scopus

 

🎓 Early Academic Pursuits


From the very beginning of his academic journey, Professor Jun Liu demonstrated exceptional dedication to the medical sciences. He earned his M.D. and laid a solid foundation in radiology, developing a keen interest in diagnostic imaging and neurological disorders. His academic commitment and intellectual curiosity propelled him toward advanced studies and laid the groundwork for a distinguished career in radiology. As a student and early-career academic, he was recognized for his strong analytical skills and leadership potential, setting the stage for the impactful roles he would later assume in both clinical and academic spheres.

🏥 Professional Endeavors


Professor Jun Liu currently serves as the Chief Radiologist and Director of the Radiology Department at the prestigious Second Xiangya Hospital of Central South University. In this role, he oversees cutting-edge radiological practices while also guiding clinical decision-making with expertise and precision. As a Doctoral Supervisor and Professor, he mentors a new generation of radiologists, integrating academic knowledge with clinical excellence. His influence also extends into organizational leadership as the Secretary of the First Party Branch, showcasing his commitment to institutional development and medical governance.

🔬 Contributions and Research Focus


A pivotal force in radiology, Professor Liu has devoted much of his research to neuroimaging and neuroregeneration. His work as the headman of the Neuroregeneration and Neuroimaging Group under the Chinese Research Hospital Association reflects his influence in shaping national research priorities. As a peer review expert for the National Natural Science Foundation of China, he contributes to the advancement of scientific standards and research integrity. His projects often intersect clinical imaging with neuroscience, allowing for better diagnosis and understanding of neurological diseases.

🏅 Accolades and Recognition


Professor Liu’s contributions have earned him numerous national honors. Notably, he was awarded the Advanced Individual against COVID-19 by the Ministry of Science and Technology of the People’s Republic of China, acknowledging his dedication during a critical period in global health. He received the Outstanding Style Award at the 5th People’s Famous Doctor Ceremony, and has been recognized as a leading talent in the Science and Technology Innovation Program of Hunan Province. His role as leader of 225 subjects in the province showcases his broad expertise and leadership in medical research and education.

🌐 Impact and Influence


Nationally, Professor Liu plays a vital role in shaping radiological standards and neurology practices. As a member of the Neurology Group under the Chinese Society of Radiology and the Chinese Medical Association, his insights influence nationwide healthcare policies and training programs. In Hunan, he is the Director of the Diagnostic Radiology Quality Control Center and President of the Radiologists Branch of the Hunan Medical Doctor Association, where he continues to elevate diagnostic standards and ensure quality in radiological services.

🚀 Innovation and Leadership


Professor Liu stands as a prime example of a “Double Leaders” Party Branch Secretary, a title awarded by the Ministry of Education, symbolizing excellence in both administrative and academic leadership. His involvement in technology-driven projects, particularly those that integrate AI and neuroimaging, highlights his forward-thinking approach to medical diagnostics. He champions the evolution of radiology into a more dynamic and precision-focused discipline, blending traditional expertise with technological innovations.

📘 Legacy and Future Contributions


As Professor Liu continues to mentor doctoral candidates and lead national research groups, his legacy is already visible in the improved radiological practices across China. His work in neuroregeneration and imaging not only enhances clinical outcomes but also pushes the boundaries of what medical imaging can achieve. In the years to come, his continued dedication to education, research, and innovation will undoubtedly shape the future of radiology and contribute to better neurological healthcare nationwide and beyond.

Publication

  • Title: Insulinoma detection on low-dose pancreatic CT perfusion: comparing with conventional contrast-enhanced CT and MRI
    Authors: S. Luo, X. Mei, Y. Shang, … W. Yang, J. Liu
    Year: 2025

 

  • Title: Functions and application of circRNAs in vascular aging and aging-related vascular diseases
    Authors: S. He, B. Huang, F. Xu, … X. Lin, J. Liu
    Year: 2025

 

  • Title: Persistent alterations in gray matter in COVID-19 patients experiencing sleep disturbances: a 3-month longitudinal study
    Authors: K. Zhou, G. Duan, Y. Liu, … J. Yang, D. Deng
    Year: 2025

 

  • Title: Multimodal radiopathological integration for prognosis and prediction of adjuvant chemotherapy benefit in resectable lung adenocarcinoma: A multicentre study
    Authors: H. Lin, J. Hua, Z. Gong, … C. Lu, Z. Liu
    Year: 2025

 

  • Title: Prognostic and predictive values of a multimodal nomogram incorporating tumor and peritumor morphology with immune status in resectable lung adenocarcinoma
    Authors: H. Lin, J. Hua, Y. Wang, … J. Liu, Z. Liu
    Year: 2025

 

  • Title: White matter microstructural alterations are associated with cognitive decline in benzodiazepine use disorders: a multi-shell diffusion magnetic resonance imaging study
    Authors: M. Yi, T. Wang, X. Li, … J. Liu, H. Zhou
    Year: 2025

 

  • Title: Unveiling causal relationships between addiction phenotypes and inflammatory cytokines: insights from bidirectional mendelian randomization and bibliometric analysis
    Authors: S. Cao, L. Yang, X. Wang, … S. Tang, J. Liu
    Year: 2025

 

  • Title: Microstructure changes of the brain preceded glymphatic function changes in young obesity with and without food addiction
    Authors: M. Yi, Z. Yule, W. Song, … J. Liu, H. Zhou
    Year: 2025

 

  • Title: Distinct insula subdivisions of resting-state functional connectivity in individuals with opioid and methamphetamine use disorders
    Authors: W. Yang, X. Wen, Z. Du, … K. Yuan, J. Liu
    Year: 2025

 

  • Title: Unraveling the Diffusion MRI-Based Glymphatic System Alterations in Children with Rolandic Epilepsy
    Authors: Y. Yin, M. Ma, F. Wang, … J. Liu, H. Liu
    Year: 2025

 

✅ Conclusion


Professor Jun Liu’s career embodies the intersection of clinical expertise, scientific innovation, and compassionate leadership. Through decades of dedication, he has transformed radiological practice and training in China, especially in neurological diagnostics. As a scholar, mentor, and administrator, his legacy continues to inspire the next generation of medical professionals. With a focus on advancing neuroimaging techniques and quality standards, Professor Liu stands as a beacon of excellence in modern radiology, with his future contributions set to further shape the landscape of medical diagnostics and research.

Peng Jun | Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Peng Jun | Cellular Neuroscience | Best Researcher Award

Prof. Peng Jun, Qilu hospital of Shandong University, China.

Professor Jun Peng is a distinguished leader in hematology, currently serving as Vice President of Qilu Hospital of Shandong University and Director of the Department of Hematology. His research is deeply rooted in the immunological pathogenesis and immune tolerance of primary immune thrombocytopenia (ITP), where he has made significant breakthroughs, including the publication of 14 papers in Blood. With a career supported by prestigious national awards, and leadership in 15 high-level research projects, Professor Peng is also a vital figure in Chinese hematology societies and editorial boards of leading journals. His academic rigor, clinical insight, and mentorship continue to shape the future of hematological science in China and beyond.

Profile

Scopus

🎓 Early Academic Pursuits

Professor Jun Peng embarked on his academic journey with a strong commitment to medicine and hematological sciences. From the outset, he exhibited exceptional academic talent and dedication, leading him to pursue both an M.D. and Ph.D. His early education laid a robust foundation for his future specialization in hematology, particularly in the complex field of immunological disorders. His doctoral work, recognized nationally, foreshadowed the groundbreaking contributions he would later make in immune thrombocytopenia research.

🩺 Professional Endeavors

Currently serving as the Vice President of Qilu Hospital of Shandong University, Professor Peng also holds the roles of Chief Physician, Professor, and Ph.D./M.D. Advisor, in addition to being the Director of the Department of Hematology. His clinical and academic responsibilities are carried out with unwavering diligence, mentoring future medical experts while overseeing high-level clinical operations. As a Distinguished Professor of Shandong University, he is actively engaged in shaping the university’s medical excellence on both national and global stages.

🔬 Contributions and Research Focus

At the heart of Professor Peng’s career is his pioneering work on the immunological pathogenesis and immune tolerance of primary immune thrombocytopenia (ITP). He has made substantial contributions to understanding the autoimmune mechanisms that underlie ITP, one of the most challenging hematologic disorders. His scholarly dedication is evidenced by the publication of 14 papers in Blood, a leading journal in hematology, where he served as corresponding or co-corresponding author. His research, grounded in clinical insight and scientific precision, has contributed new perspectives on immune regulation in hematologic diseases.

🏆 Accolades and Recognition

Professor Peng’s excellence has been recognized with numerous prestigious awards. These include the National Science Fund for Distinguished Young Scholars, which highlights his scientific creativity and impact at a young age. He is also a recipient of the One-Hundred National Outstanding Doctoral Dissertation Award, a testament to the academic rigor of his early research. Additionally, he earned the First Prize of the Natural Science Award for Outstanding Achievements in Scientific Research from the Ministry of Education and the Science and Technology Progress Award, reflecting both his academic brilliance and practical impact in the medical field.

🧪 Impact and Influence

Beyond research publications, Professor Peng has significantly influenced the broader scientific and medical communities. As a principal investigator, he has led fifteen national and ministerial-level research projects, including those funded by the National Natural Science Foundation of China and the 973 Program under the Ministry of Science and Technology. His leadership extends to active roles in national academic societies, including the Thrombosis and Hemostasis Group of the Chinese Society of Hematology and the Professional Committee of Experimental Hematology of the Chinese Society of Pathophysiology. These positions allow him to shape the direction of hematological research and clinical guidelines in China.

📚 Academic Leadership and Editorial Roles

A passionate advocate for knowledge dissemination, Professor Peng is a key editorial board member for several respected journals such as Thrombosis Journal, Thrombosis Research, Journal of Clinical Hematology, and the Chinese Journal of Hematology. Through these roles, he ensures that cutting-edge research in hematology is critically evaluated and shared widely, fostering a culture of scientific excellence and collaboration across the globe.

🌟 Legacy and Future Contributions

Professor Jun Peng’s legacy is being forged not only through his past achievements but also through his continued commitment to the advancement of hematological science. His influence spans clinical innovation, academic mentorship, and scientific discovery. As he continues to push the boundaries of understanding in ITP and immune tolerance, he inspires a new generation of physician-scientists. The impact of his work promises to resonate for years to come, offering hope and healing for patients and propelling China’s medical research onto the world stage.

Publication

  • Title: Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)
    Authors: Qizhao Li, Geneviève Marcoux, Yuefen Hu, Jung Peng, John W. Semple
    Year: 2024

 

  • Title: Quantitative detection of macular microvascular abnormalities identified by optical coherence tomography angiography in different hematological diseases
    Authors: Tianzi Jian, Fabao Xu, Guihua Li, Li Zhang, Jung Peng
    Year: 2024

 

  • Title: Nicotinamide enhances Treg differentiation by promoting Foxp3 acetylation in immune thrombocytopenia
    Authors: Ju Li, Cheng Zhang, Yuefen Hu, Qi Feng, Xiang Hu
    Year: 2024

 

  • Title: The effects of complement-independent, autoantibody-induced apoptosis of platelets in immune thrombocytopenia (ITP)
    Authors: Lin Sun, Yichen Zhang, Ping Chen, Jung Peng, Zi Sheng
    Year: 2024

 

  • Title: Post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: a case report, meta-analysis, and systematic review
    Authors: You Yuan Su, Yafei Yu, Zhenyu Yan, Jung Peng, Xinguang Liu
    Year: 2024

 

  • Title: Ion channel Piezo1 activation aggravates the endothelial dysfunction under a high glucose environment
    Authors: Xiaoyu Zhang, Shaoqiu Leng, Xinyue Liu, Shuwen Wang, Jung Peng
    Year: 2024

 

  • Title: Intelligent dual-modality label-free cell classification with light scattering imaging and Raman spectra measurements
    Authors: Faihaa Mohammed Eltigani, Xiaoyu Zhang, Min Liu, Jung Peng, Xuantao Su
    Year: 2024

 

  • Title: Eltrombopag plus diacerein vs eltrombopag in patients with ITP: a multicenter, randomized, open-label phase 2 trial
    Authors: Lu Sun, Xiaoyang Huang, Juan Wang, Ming Hou, Yu Hou
    Year: 2024

 

  • Title: Risk Factors for Mortality in Critically Ill Patients with Coagulation Abnormalities: A Retrospective Cohort Study
    Authors: Qiuyu Guo, Jung Peng, Tichao Shan, Miao Xu
    Year: 2024

 

  • Title: Platelet-derived TGF-β1 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia
    Authors: Lingjun Wang, Haoyi Wang, Mingfang Zhu, Ming Hou, Yu Hou
    Year: 2024

 

✅ Conclusion

Through his pioneering research, unwavering clinical dedication, and impactful academic leadership, Professor Jun Peng stands at the forefront of immuno-hematology. His work not only deepens scientific understanding of ITP but also contributes directly to improved patient outcomes. As he continues to inspire through teaching, research, and innovation, Professor Peng’s legacy is one of excellence, influence, and ongoing transformation in the global hematology community.

 

Handrean Soran | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Handrean Soran | Clinical Neuroscience | Best Researcher Award

Prof. Handrean Soran,  Manchester University NHS Foundation Trust, United Kingdom.

Dr. Handrean Soran is a distinguished British endocrinologist and researcher with expertise in diabetes, endocrinology, and cardiovascular diseases. His academic journey began in Iraq and advanced through the UK, where he earned prestigious medical qualifications, including an MD in Medicine and MSc in Diabetes and Endocrinology. Throughout his career, Dr. Soran has contributed significantly to research on the relationship between diabetes and cardiovascular health, publishing extensively in high-impact journals like The New England Journal of Medicine and Lancet. His work has garnered global recognition, including an H-index of 49 and numerous accolades, solidifying his position as a leader in his field.

Profile

Google Scholar

 

Early Academic Pursuits 📚

Handrean Soran’s academic journey began in the Kurdistan region of Iraq, where he completed his A-levels with an impressive score of 94.5% from Sulemani High School in 1985. His drive for knowledge led him to pursue his MBChB at Al-Mustansyria University in Baghdad, Iraq, graduating in 1990. This foundational education set the stage for a career dedicated to medical research and practice. After completing his medical degree, he pursued further specialized training in the UK, where he earned his MRCP from the Royal College of Physicians in Edinburgh in 1999, and later, an MSc in Diabetes and Endocrinology from the University of Liverpool in 2006. These early academic milestones laid the foundation for his later expertise in endocrinology and diabetes, fields that would define his career.

Professional Endeavors 🏥

Dr. Handrean Soran’s professional journey is marked by a dedication to medicine, particularly in the fields of endocrinology and diabetes. He has held significant roles in prestigious institutions, with his current position in the Department of Diabetes, Endocrinology, and Metabolism at Manchester University Hospitals NHS Foundation Trust. His medical career was further enhanced by his qualifications as a Fellow of the Royal College of Physicians (FRCP) from both Glasgow and Edinburgh. Throughout his career, Dr. Soran has worked on developing innovative approaches in clinical care and research, constantly striving to improve patient outcomes and advancing medical knowledge.

Contributions and Research Focus 🔬

Dr. Soran’s research focus primarily centers on diabetes, endocrinology, and cardiovascular health, specifically the interplay between metabolic disorders and heart disease. His research efforts have been integral to understanding the link between diabetes and cardiovascular risk, with a significant body of work examining the effects of treatments on these interconnected conditions. His contributions have been recognized through multiple high-impact publications in renowned journals such as the New England Journal of Medicine, Lancet, and European Heart Journal. With an H-index of 49 and over 130 citations, Dr. Soran’s work continues to shape the clinical landscape in these areas, driving further advancements in treatment protocols and therapeutic strategies for diabetes and cardiovascular diseases.

Accolades and Recognition 🏆

Dr. Soran’s career has been decorated with numerous accolades, affirming his status as a leader in his field. He achieved the prestigious title of Fellow of the Royal College of Physicians (FRCP) in both Edinburgh and Glasgow, a testament to his clinical expertise and contribution to medical science. His groundbreaking work in diabetes and cardiovascular research has earned him recognition not only from peers but also from major medical institutions. His publications in top-tier journals further highlight his academic prowess, solidifying his position as a key thought leader in the medical and academic communities.

Impact and Influence 🌍

Dr. Handrean Soran’s work extends beyond the realm of research publications; it has made a lasting impact on the clinical management of diabetes and cardiovascular diseases worldwide. His insights have contributed to shaping healthcare policies and clinical practices, particularly in the management of diabetic patients at high cardiovascular risk. Through his collaboration with the Division of Cardiovascular Sciences at the University of Manchester, he has fostered interdisciplinary approaches to solving complex medical challenges, advancing the integration of cardiovascular care with endocrinology. His work has influenced not only academic circles but also clinical practice, providing new directions for patient care.

Legacy and Future Contributions 🌱

As Dr. Soran continues his impactful work, his legacy is one of dedication to improving patient health outcomes and advancing the fields of endocrinology and diabetes. With a deep commitment to teaching and mentorship, Dr. Soran plays a pivotal role in training the next generation of doctors and researchers. His future contributions are poised to further explore the intricate relationship between metabolic disorders and cardiovascular health, addressing the growing global burden of these interconnected diseases. His work will undoubtedly continue to guide both clinical practice and future research in endocrinology, diabetes, and cardiovascular medicine, ensuring his ongoing influence in these critical areas.

Global Recognition and Influence 🌐

Dr. Soran’s influence reaches across borders, as evidenced by his extensive publication record and recognition within the global medical community. His research has not only enriched the scientific literature but also contributed to global health initiatives, particularly in the area of metabolic disorders and cardiovascular diseases. With collaborations spanning multiple continents, Dr. Soran is dedicated to improving health outcomes globally, offering expert insights into the prevention and management of diabetes and heart disease. His role in shaping clinical guidelines and his participation in international research collaborations further amplify his global impact.

Academic and Professional Leadership 🎓

In addition to his research contributions, Dr. Soran’s leadership within academia is profound. He holds multiple academic positions, including his affiliation with the University of Manchester, where he plays an integral role in advancing research within the Division of Cardiovascular Sciences. His leadership extends to mentoring young researchers and clinicians, helping to foster a new generation of experts in endocrinology and diabetes. Dr. Soran’s academic vision continues to drive progress in both education and research, making significant strides in improving how diabetes and cardiovascular diseases are understood and treated. His future work promises to leave a lasting mark on medical education and the advancement of scientific knowledge.

Publication

  • Cardiovascular efficacy and safety of bococizumab in high-risk patients
    Author: PM Ridker
    Year: 2017

 

  • Volanesorsen and triglyceride levels in familial chylomicronemia syndrome
    Author: JL Witztum
    Year: 2019

 

  • Triglyceride lowering with pemafibrate to reduce cardiovascular risk
    Author: A Das Pradhan
    Year: 2022

 

  • Diabetes dyslipidemia
    Author: JD Schofield
    Year: 2016

 

  • Lysosomal acid lipase deficiency–an under-recognized cause of dyslipidaemia and liver dysfunction
    Author: Ž Reiner
    Year: 2014

 

  • Obesity: a critical risk factor in the COVID‐19 pandemic
    Author: S Kwok
    Year: 2020

 

  • Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
    Author: KK Ray
    Year: 2019

 

  • Hypercholesterolaemia and its management
    Author: D Bhatnagar
    Year: 2008

 

  • Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
    Author: B Williams
    Year: 2018

 

  • Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset …
    Author: FJ Raal
    Year: 2017

 

Conclusion

Dr. Handrean Soran’s career is marked by profound contributions to medical science, particularly in the fields of diabetes and cardiovascular health. His groundbreaking research and clinical expertise have had a significant impact on both academic and healthcare practices worldwide. As a recognized leader in his field, Dr. Soran’s work continues to influence the management of metabolic and cardiovascular diseases, and his future contributions promise to further advance these critical areas of medical research and practice. His legacy is one of dedication, leadership, and a commitment to improving health outcomes globally.